Abstract Background The EQ-5D has been extensively used to assess patient utility in trials
of new treatments within the cardiovascular field. The aims of this study were to review …

Health care spending has risen steadily in most countries, becoming a concern for decision-
makers worldwide. Commentators often point to new medical technology as the key driver …

Background The EQ-5D is a preference based instrument which provides a description of a
respondent's health status, and an empirically derived value for that health state often from a …

Background No prospective trial-based data are available for incremental cost-effectiveness
of drug-eluting stents (DES) compared with bare-metal stents (BMS) in unselected patients …

Background: Published guidelines on the conduct of economic evaluations provide little
guidance regarding the use and potential bias of the different costing methods. Objectives …

Aims To examine the cost-effectiveness of intravascular ultrasound (IVUS) use during
percutaneous coronary intervention (PCI) with drug-eluting stents (DES) in treating coronary …

The major benefit of DES is a reduction in the rate of restenosis after PCI. Therefore, to
understand the clinical and economic impact of DES, the overall scope and consequences …

Objective To assess the cost utility of a center-based outpatient cardiac rehabilitation
program compared with no program within patient subgroups on the basis of age, sex, and …

Objective To evaluate the comparative cost‐effectiveness of interventions to improve
adherence to evidence‐based medications among postmyocardial infarction (MI) patients …

Objectives: This study sought to compare aggregate medical care costs for patients
undergoing percutaneous coronary intervention with paclitaxel-eluting stents (PES) and …